中大職務
- 病理解剖及細胞學系系主任及教授
專業範疇
- 乳腺病理學
教育及資歷
MBBS(HK), FRCPC, FCAP, DAB(AP), FRCPath
專注研究
- 乳腺癌形態學特徵的分子基礎
- 乳腺癌的診斷和預後指標
- 乳腺病變（纖維上皮樣病變、乳頭狀病變）的發病機制及診斷
- 乳腺疾病的細胞病理學特徵
更多資訊
專業服務
- 雅麗氏何妙齡那打素醫院病理學系榮譽部門主管
- 北區醫院病理學系榮譽部門主管
- 新界東聯網榮譽顧問醫生
部分論文 (只有英文版本)
- Li Y, Tsang JY, Tam F, Loong T, Tse GM. Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment. EBioMedicine.2023 May;91:104571.
- Ellis IO, Rakha EA, Tse GM, Tan PH. An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative. Histopathology. 2023 Jan;82(1):189-197
- Tsang JY, Shao Y, Poon IK, Ni YB, Kwan JS, Chow C, Shea KH, Tse GM. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology. 2022 Oct;54(6):678-685.
- Ni Y, Tsang JY, Shao Y, Poon IK, Tam F, Shea KH, Tse GM. Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes. Oncologist. 2022 Apr 5;27(4):e313-e327.
- Thennavan A, Beca F, Xia Y, Recio SG, Allison K, Collins LC, Tse GM, Chen YY, Schnitt SJ, Hoadley KA, Beck A, Perou CM. Molecular analysis of TCGA breast cancer histologic types. Cell Genom. 2021 Dec 8;1(3):100067.
- Poon IK, Tsang JY, Li J, Chan SK, Shea KH, Tse GM. The significance of highlighting the oestrogen receptor low category in breast cancer. Br J Cancer. 2020 Oct;123(8):1223-1227.
- Lai BS, Tsang JY, Poon IK, Shao Y, Chan SK, Tam FK, Cheung SY, Shea KH, Tse GM. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas. Oncologist. 2020 Sep;25(9):e1318-e1329.
- Tsang JY, Ho CS, Ni YB, Shao Y, Poon IK, Chan SK, Cheung SY, Shea KH, Marabi M, Tse GM. Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers. Cancer Immunol Immunother. 2020 May;69(5):799-811.
- Liu X, Tsang JYS, Hlaing T, Hu J, Ni YB, Chan SK, Cheung SY, Tse GM. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers. Oncologist. 2017 Nov;22(11):1316-1324.
- Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017 Feb;241(3):375-391.